Previous studies have shown that in gallbladder cancer cells, eIF3d leads to tumour progression via stable expression of G-protein coupled receptor kinase 2 (GRK2) and activation of the phosphatidylinositol 3-kinase (PI3K)-AKT signalling pathway [35]. The gene discussed is GRK2; the disease is gallbladder cancer.